The historical rank and industry rank for Co-Diagnostics's FCF Margin % or its related term are showing as below:
CODX'
s FCF Margin % Range Over the Past 10 Years
Min: -41750 Med: -763.81 Max: 41.28
Current: -853.53
During the past 10 years, the highest FCF Margin % of Co-Diagnostics was 41.28%. The lowest was -41750.00%. And the median was -763.81%.
CODX's FCF Margin % is ranked worse than 93.89% of 818
companies
in the Medical Devices & Instruments industry
Industry Median: -2.57
vs CODX: -853.53
Co-Diagnostics FCF Margin % Historical Data
The historical data trend for Co-Diagnostics's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Co-Diagnostics's FCF Margin %
For the Medical Devices subindustry, Co-Diagnostics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Co-Diagnostics's FCF Margin % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Co-Diagnostics's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Co-Diagnostics's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Co-Diagnostics FCF Margin % Related Terms
Thank you for viewing the detailed overview of Co-Diagnostics's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CODX has been successfully added to your 